AI assistant
Coloplast — Director's Dealing 2021
May 21, 2021
3358_rns_2021-05-21_0dface30-1b4b-4f2c-b94c-28a0b5b591cd.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Announcement
21 May 2021
Coloplast
Ostomy Care
Continence Care
Wound & Skin Care
Interventional Urology
Coloplast A/S
Holtedam 1
3050 Humlebæk
Danmark
Tlf: 4911 1111
www.coloplast.com
CVR-nr. 69749917
Report on transactions of executives and related parties in Coloplast shares and related securities
According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transaction concerns purchase of shares.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
|---|---|---|---|
| a) | Name | Gerda Louis-Hansen | |
| 2 | Reason for the notification | ||
| a) | Position/status | Related party to Niels Peter Louis-Hansen (deputy chairman) | |
| b) | Initial notification/Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Coloplast A/S (CVR-no.: 69749917) | |
| b) | LEI | 529900NN750J5QG82X67 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | ||
| Identification code | B shares | ||
| ISIN: DK0060448595 (B shares) | |||
| b) | Nature of the transaction | Purchase of shares | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| 960,40 | 123 | ||
| 960,30 | 76 | ||
| 960,40 | 78 | ||
| 960,30 | 69 | ||
| 960,40 | 66 | ||
| 960,30 | 68 | ||
| 960,30 | 66 | ||
| 960,30 | 64 | ||
| 960,30 | 66 | ||
| 960,20 | 98 | ||
| 960,80 | 60 | ||
| 960,80 | 60 | ||
| 960,80 | 6 |
Page 1 of 4
| 961,00 | 23 |
|---|---|
| 961,00 | 44 |
| 961,00 | 7 |
| 961,00 | 7 |
| 961,00 | 44 |
| 961,00 | 55 |
| 960,40 | 78 |
| 960,70 | 74 |
| 960,80 | 19 |
| 960,80 | 1 |
| 960,80 | 22 |
| 960,40 | 79 |
| 960,40 | 65 |
| 960,40 | 57 |
| 960,40 | 88 |
| 962,00 | 51 |
| 962,00 | 143 |
| 963,20 | 44 |
| 963,80 | 144 |
| 963,00 | 64 |
| 963,20 | 35 |
| 963,20 | 23 |
| 962,40 | 5 |
| 962,40 | 3 |
| 962,40 | 3 |
| 963,00 | 76 |
| 963,00 | 41 |
| 962,00 | 46 |
| 962,00 | 113 |
| 962,00 | 24 |
| 961,40 | 49 |
| 961,40 | 63 |
| 961,40 | 76 |
| 961,20 | 60 |
| 961,20 | 6 |
| 961,20 | 46 |
| 961,20 | 132 |
| 961,20 | 11 |
| 961,80 | 46 |
| 961,80 | 140 |
| 962,00 | 60 |
| 962,00 | 24 |
| 962,00 | 20 |
| 962,00 | 6 |
| 961,40 | 126 |
| 961,40 | 50 |
| 961,40 | 18 |
| 960,80 | 30 |
| 960,80 | 22 |
| 960,80 | 138 |
| 960,80 | 3 |
| 960,40 | 79 |
| 960,30 | 73 |
Page 2 of 4
| 960,40 | 76 | ||
|---|---|---|---|
| 960,40 | 74 | ||
| 960,00 | 74 | ||
| 960,00 | 114 | ||
| 960,20 | 69 | ||
| 960,00 | 51 | ||
| 960,30 | 79 | ||
| 960,40 | 27 | ||
| 960,80 | 83 | ||
| 960,80 | 17 | ||
| 960,80 | 97 | ||
| 960,20 | 77 | ||
| 960,40 | 66 | ||
| 961,20 | 74 | ||
| 961,20 | 20 | ||
| 961,60 | 53 | ||
| 961,60 | 121 | ||
| 961,60 | 37 | ||
| 961,80 | 36 | ||
| 963,80 | 121 | ||
| 963,80 | 3 | ||
| 963,40 | 60 | ||
| 963,40 | 23 | ||
| 963,40 | 26 | ||
| 962,60 | 66 | ||
| d) | Aggregated information | ||
| - Aggregated volume | |||
| - Price | 5,200 shares | ||
| DKK 961.23 (volume weighted average) | |||
| e) | Date of the transaction | 2021-05-19, 14:32 UTC (last trade) | |
| f) | Place of the transaction | Nasdaq Copenhagen A/S (XCSE) |
This information is available in Danish and in English, in case of doubt the Danish version prevails.
For further information: Hannah Katrine Larsen, tel.: +45 4911 3616.
Coloplast
Ostomy Care
Continence Care
Wound & Skin Care
Interventional Urology
Our mission
Making life easier for people
with intimate health care needs
Our values
Closeness... to better understand
Passion... to make a difference
Respect and responsibility... to guide us
Our vision
Setting the global standard
for listening and responding
For further information, please contact
Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111
Ellen Bjurgert
Vice President, Investor Relations
Tel. +45 4911 1800 / +45 4911 3376
Email: [email protected]
Aleksandra Dimovska
Sr. Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 2458
Email: [email protected]
Press and media
Peter Mønster
Sr. Media Relations Manager
Tel. +45 4911 2623
Email: [email protected]
Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917
Website
www.coloplast.com
This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,500 employees.
The Coloplast logo is a registered trademark of Coloplast A/S. © 2021-05.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.
Page 4 of 4